Yumanity Therapeutics
2014
FOUNDED
PRIVATE
STATUS
21-30
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$31.1M
LATEST DEAL AMOUNT
7
INVESTORS
Description
Developer of innovative drugs intended to be used for the treatment of neurodegenerative diseases caused by protein misfolding. The company's innovative drugs specialize in the research and development of therapies for patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, enabling healthcare institutions to effectively cure neurodegenerative diseases and help patients lead a healthy life.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 790 Memorial Drive
- Suite 2C
- Cambridge, MA 02139
- United States
+1 (617) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Yumanity Therapeutics’s full profile, request a free trial.
Yumanity Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 29-Jun-2018 | $31.1M | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 18-Feb-2016 | 0000 | 0000 | Completed | Startup | |
| 1. Seed Round | Completed | Startup |
Yumanity Therapeutics Competitors (25)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Iconic Therapeutics | Venture Capital-Backed | South San Francisco, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 0000000 | Venture Capital-Backed | Framingham, MA | 0 | 0000 | 00000000 | |
| 0000000 | Venture Capital-Backed | CA | 000.00 | 00000000000 | 000.00 | |
| 000000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 00000000 | 00000 |
| 000 00000000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
Yumanity Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Pfizer Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Biogen | Corporation | Minority | 000 0000 | 000000 0 | ||
| Dolby Family Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Fidelity Management & Research | Asset Manager | Minority | 000 0000 | 000000 0 |
Yumanity Therapeutics Executive Team (9)
1 Former Executive
You’re viewing 5 of 9 executives. Get the full list »Yumanity Therapeutics Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Cecil Pickett Ph.D | Self | Board Member | 000 0000 | |
| Jeffery Kelly Ph.D | Self | Board Member | 000 0000 | |
| Joel Marcus JD | Alexandria Venture Investments | Board Member | 000 0000 | |
| John Cox | Self | Board Member | 000 0000 | |
| N. Coles MD | Yumanity Therapeutics | Co-Founder, Chairman and Chief Executive Officer | 000 0000 |